Kyrgyzstan vs Libya: Cause of death, by non-communicable diseases, ages 60+
Kyrgyzstan
71.1%
in 2021
Libya
70.8%
in 2021
Kyrgyzstan rank
100th
Libya rank
101st
Cause of death, by non-communicable diseases, ages 60+ over time
- Kyrgyzstan
- Libya
How they compare
Kyrgyzstan currently reports 71.1% against 70.8% in Libya, a difference of 0.3%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Kyrgyzstan ahead.
Kyrgyzstan ranks 100th and Libya ranks 101st of 185 countries.
Across the 3 decades both report, Kyrgyzstan averaged higher in 2 and Libya in 1.
Head to head by decade
| Decade | Kyrgyzstan | Libya | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 95.7% | 90.2% | 5.5% | Kyrgyzstan |
| 2010s | 96.4% | 90.7% | 5.7% | Kyrgyzstan |
| 2020s | 72.5% | 75.8% | 3.3% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, Kyrgyzstan or Libya?
- Kyrgyzstan, at 71.1% against 70.8% in Libya as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between Kyrgyzstan and Libya?
- 0.3%, with Kyrgyzstan ahead.
- How many years of comparable data are there for Kyrgyzstan and Libya?
- 6 years are reported by both, from 2000 to 2021.
- How do Kyrgyzstan and Libya rank globally for cause of death, by non-communicable diseases, ages 60+?
- Kyrgyzstan ranks 100th and Libya ranks 101st of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.